PipelinePharma Logo

Generics

Originals

Biosimilars

Medical devices

Nutraceuticals 2

Filters

Saccharomyces cerevisiae manufacturers

2 products found

Filters

Filters

Filters , active

Country of origin : Italy

Clear all

2 products found

saccharomyces cerevisiae + fos + lactobacillus plantarum + l-tryptophan + boswellia

Capsules 250 mg + 50 mg + 2.5 billion CFU + 100 mg + 35 mg

Country of origin
European Union
GMP approvals
EU GMP
Recommended use
Probiotics
Product description
Food supplement based on FOS, yeast and lactic ferments with boswellia extract, useful for the functionality of the digestive system, and tryptophan. Gluten-free.
Manufacturer #28078

Manufacturer usually replies in 1 days

Want to see all 2 products?

Subscribe today to benefit from:

  • Streamlined product sourcing - the leading CTD dossiers database focused on finished dosage formulations

  • Direct negotiations - connect and negotiate directly with manufacturers without any brokerage fee

  • Increased profitability - secure the best commercial terms for your business by comparing offers from several manufacturers

Request Subscription

Popular Searches

Amoxicillin manufacturers Atorvastatin manufacturers Benzocaine manufacturers Calcium carbonate manufacturers Cloperastine fendizoate manufacturers Gabapentin manufacturers Hyaluronic acid manufacturers Ibuprofen manufacturers Ivermectin manufacturers Levothyroxine manufacturers Lisinopril manufacturers Losartan manufacturers Magnesium manufacturers Melatonin manufacturers Metformin manufacturers Methotrexate manufacturers Metoprolol manufacturers Omeprazole manufacturers Paracetamol manufacturers Prednisone manufacturers Pregabalin manufacturers Semaglutide manufacturers Testosterone enanthate manufacturers Vitamin B12 manufacturers

Interested in becoming a subscriber?

Please provide the following information to receive an offer tailored to your business needs

  1. Number of company users for the subscription
  2. The rough number of products you would like to source in the 12 months
  3. Target market(s) for commercialisation